Semen analysis lacks a functional component and best identifies extreme cases of infertility. The ganglioside G M1 is known to have functional roles during capacitation and acrosome exocytosis.
This is a global problem, with male factor reported to contribute to between 50% and 70% of cases of infertility in several regions, and with rates of male infertility ranging from 2.5% to 12% (Agarwal et al., 2015) . In the United States, 7.5% of men aged 45 years or younger (3.3-4.7 million men) reported seeing a fertility doctor (Chandra, Martinez, Mosher, Abma, & Jones, 2005) . Despite the enormous and growing importance of male factor infertility worldwide, diagnostic assays for male fertility remain inadequate; the lack of sperm function tests is a particular deficit (Lamb, 2010; Oehninger, Franken, & Ombelet, 2014; Wang & Swerdloff, 2014) .
The diagnosis of male infertility is currently heavily based on results of standard semen analysis, which includes the evaluation of sperm morphology, concentration, and motility. The World Health Organization establishes and updates reference values for standard semen analysis in an attempt to distinguish normal from abnormal ejaculates (World Health Organization, 2010) . Normal measures are defined as sperm concentration of ≥15 × 10 6 /ml, total motility of ≥40%, and morphology (Krueger strict criteria) as ≥4% normal forms (Cooper et al., 2010; World Health Organization, 2010 ).
However, a methodological concern with the generation and use of these 2010 World Health Organization values exists. Although the lower reference limits (5th percentile) were obtained utilizing data generated from a population of 4,500 fertile men from 14 countries (Cooper et al., 2010) , data from potential subfertile/infertile men were not taken into account. Evidence of the inadequacy of semen analysis to reflect male fertility status is raised by clinical studies highlighting the absence of correlation between semen analysis results and ability to fertilize (Guzick et al., 2001; Ombelet et al., 1997; van der Steeg et al., 2011) . In fact, van der Steeg et al. (2011) showed that men with normal and abnormal semen parameters were comparable in generating spontaneous pregnancies. This group argued that semen analysis still has value, but the individual parameters must be used in aggregate with one another, as opposed to being considered in terms of simple cut-offs (van der Steeg et al., 2011) .
Another factor contributing to concern about the utility of semen analysis is the high variability among different ejaculates from the same individual. An intra-individual variability of 34% in sperm concentration was observed when at least three ejaculates were examined, and the coefficient of variation remained high even when factors such as abstinence and fever were taken into account (Carlsen, Petersen, Andersson, & Skakkebaek, 2004) . Another study reported very similar results, showing a variance of 54% for concentration and 74% for motility index (Mallidis, Howard, & Baker, 1991) . Together, these findings on the descriptive and varying nature of the parameters of semen analysis led to an understanding that the majority of infertile men have defects in sperm function. These, unfortunately, are only diagnosed by repeated failed cycles of intrauterine insemination (Aboulghar et al., 2001; Tournaye, 2012) .
One aspect of sperm function that has received much attention as the potential basis for a diagnostic assay is the process of sperm functional maturation known as "capacitation." During capacitation, sperm acquire the ability to fertilize an egg. In vivo, sperm capacitation occurs while the sperm travel through the female reproductive tract (Austin, 1951 (Austin, , 1952 Chang, 1951) . Along this journey, sperm respond to stimuli and a series of molecular events renders them fertilization competent (Austin, 1952; Travis & Kopf, 2002) . Some of these molecular events include cholesterol efflux and subsequent changes in plasma membrane composition and fluidity (Davis, Byrne, & Hungund, 1979; Visconti et al., 1999) , such as altered dynamics of cholesterol and the ganglioside G M1 in the plasma membrane overlying the acrosome (Buttke, Nelson, Schlegel, Hunnicutt, & Travis, 2006; Selvaraj et al., 2006 Selvaraj et al., , 2007 Selvaraj et al., , 2009 ). Both cholesterol efflux and focal enrichment of G M1 were shown to trigger transient calcium influx through a voltage-gated channel in mouse sperm (Cohen et al., 2014) .
These transients are required for sperm to undergo acrosome exocytosis, which is a process necessary for spermatozoa to penetrate and fertilize the egg (Cohen et al., 2014) .
While investigating the role that G M1 plays in capacitation, we noted that G M1 localization occurred in specific and reproducible patterns in both murine and bovine sperm that responded to stimuli for capacitation versus those that either were not incubated with the stimuli or could not respond to them (Selvaraj et al., 2007) .
Furthermore, we demonstrated that sperm showing the G M1 localization pattern associated with capacitation represented the subpopulation that could undergo acrosome exocytosis and therefore were capable of fertilization (Selvaraj et al., 2007) . Based on these results, we performed studies with human sperm, finding localization patterns similar to those in the bull Paniza, Neri, Rosenwaks, & Palermo, 2014; Selvaraj et al., 2007) . We subsequently found that those human sperm undergoing acrosome exocytosis stemmed from the subpopulation having G M1 localization patterns corresponding with capacitation. We also found that those sperm having "capacitated" G M1 localization patterns showed evidence of communication between the plasma and outer acrosomal membranes, which was not seen in sperm having a "non-capacitated" G M1 localization pattern (Moody et al., 2017) . These data substantiated the accuracy of the assay at the single-sperm level; namely, those sperm having a capacitated G M1 localization pattern were indeed capacitated (Moody et al., 2017) . Based on these and other data regarding the precision and repeatability of the assay, we defined the Cap-Score™ as the percentage of sperm having G M1 localization patterns consistent with capacitation in relation to the total number of sperm having G M1 localization patterns.
Here, we set out to determine whether the Cap-Score could be used to indicate the fertility status of men, and therefore provide the basis for an in vitro, laboratory-developed diagnostic test of male fertility that specifically assayed sperm capacitation and functional ability to fertilize. If positive, these results would contribute to the validation of the assay (Moody et al., 2017) by providing information about the clinical accuracy, or fit-for-purpose. Historically, several assays designed to test sperm function were shown to correlate with one or more of the traditional semen analysis parameters, limiting the additional value they provided to diagnostic efforts (Aitken, 2002; Giwercman et al., 2003; Hazary, Chaudhuri, & Wishart, 2001; Zini et al., 2009) . We therefore also evaluated whether G M1 localization patterns correlated with any of the standard semen analysis parameters or instead added distinct, complementary information.
2 | RESULTS
| Experimental design
The correspondence of G M1 localization patterns in sperm with capacitation status was previously identified in the Travis lab, at
Cornell's College of Veterinary Medicine (Selvaraj et al., 2007 Several possible cut-offs were evaluated using a receiver operating characteristic curve to determine whether the Cap-Score, on its own, might be able to distinguish fertile from subfertile/infertile patients in Study 1 (Figure 2 ). When a Cap-Score cut-off of 39.5% was used, 13 patients were above the cut-off and 29 were below based on the population distribution ( Figure 1b ). Of the 13 above the cut-off, 92.3% (12/13) were fertile. Of the 29 individuals below the cut-off, 20.7% (6/29) were fertile. When a Cap-Score of 37.5% was used as a cut-off, 17 patients were above, and 25 were below. Iteratively adjusting the cut-off revealed a tradeoff between sensitivity and specificity, which behaved as expected. A cut-off of 38.0% provided the best combination of sensitivity and specificity; however, because a cut-off of 39.5% maximized sensitivity for this population ( The proportion of clinically subfertile/infertile individuals with low scores (Cap-Score <39.5%) (23/24) was larger than the proportion of clinically fertile individuals below the cut-off (6/18; p = 0.000). These results further suggested that the Cap-Score provided useful information that could help distinguish men who were likely to have success by natural conception or within three or fewer cycles of intrauterine insemination from those who were subfertile/infertile, and did not achieve clinical evidence of pregnancy within this limit.
| Spermatozoa from presumed-fertile men showed a robust response to capacitation stimuli
Despite their compelling nature, the above data had an important limitation; namely, they were obtained from individuals actively seeking a fertility work-up and treatment at a tertiary care clinic, often after a long history of examinations and failed cycles of intrauterine insemination at other clinics. This resulted in a highly skewed patient base, in terms of both age and need for the majority to utilize intrauterine insemination to achieve a successful fertilization. Thus, the values and cut-off in Study 1 would likely not be applicable to a fertile population and/or a population seeking fertility treatment.
In Study 2, we therefore set out to determine a Cap-Score To determine how consistent Cap-Score readings were within a donor, multiple samples were tested from 30 of these fertile men (average four readings/donor). Collections were done at least 1-week apart, with donor assurance of two-to-five days of abstinence. A Cap-Score was obtained for each collection, and a coefficient of variation was documented (Carlsen et al., 2004; Mallidis et al., 1991) , and these observations suggest that the Cap-Score is reasonably consistent from one collection to the next.
| Establishing a standard capacitation profile
An average Cap-Score was determined for each donor in Cohort 1 of were removed from the population of men questioning their fertility as a result of female factor infertility, making it likely that a number of these men were actually fertile.
FIGURE 2 Determining cut-off to optimize fertility designation in Study 1. A receiver operating characteristic curve was generated using CapScore and fertility history. The To compare the distributions of these two populations, we first converted the data from Cohorts 1 and 2 to z-scores using the mean (μ) and standard deviation (SD; σ) for Cohort 1 (z-score i = (X i − µ)/σ; heterogeneous distribution that includes a number of fertile men.
Nonetheless, the average Cap-Score for sperm incubated with capacitation stimuli for Cohort 2 was 31.6 ± 0.73% (n = 122), which is significantly less than the value obtained for Cohort 1 (p = 0.001).
Altogether, these data strongly suggest that the population of men questioning their fertility produced fewer sperm that could respond to capacitation stimuli.
2.6 | Minimal-to-no relationship was found between Cap-Score and standard semen analysis parameters
Several assays designed to test sperm function were previously found to correlate with one or more of the traditional semen analysis parameters, greatly reducing their diagnostic value (Aitken, 2002; Giwercman et al., 2003; Hazary et al., 2001; Zini et al., 2009 ).
Therefore, we evaluated whether Cap-Score provided novel functional data or merely tracked with standard semen analysis parameters by comparing sperm morphology, concentration, and motility metrics to the Cap-Scores for each man in Cohort 2. Cap-Score (r = 0.22, p = 0.02; r 2 = 0.05), with total motility accounting for only 5% of the variability in Cap-Score, leaving 95% of the variability unrelated to motility. As shown, total motility data were collected in an ordinal fashion, rather than as a continuous measure, so total motility data were also analyzed in bins of 5% to reflect the manner in which the data were collected. Bins having less than three observations were removed, followed by analysis of variance. No difference in Cap-Score was detected across the six bins (p = 0.14), highlighting the minor nature of any potential relationship. standard deviation below the mean, as compared to 13.2% for the fertile cohort. These data are especially remarkable in that none of the men questioning their fertility (Cohort 2) were excluded because of infertility in their female partners. Thus, one would expect a number of the men in Cohort 2 to be fertile, with a purely female factor fertility issue driving that couple to be examined (Agarwal et al., 2015) . If those fertile men had been removed from Cohort 2, then the assay might have revealed an even higher percentage of cases of men whose sperm responded poorly to stimuli for capacitation.
As noted, several assays initially thought to provide information on sperm fertilizing ability were later shown to track with one of the existing parameters of semen analysis. We found that traditional semen analysis parameters, including sperm morphology, total motility, and concentration, had little to no correlation with the Cap-Score (at most, motility accounted for 5% of the Cap-Score); thus, the Cap-Score provides novel information.
Over the past decades, several assays were shown to measure or assess sperm capacitation. For example, capacitation can be detected by performing immunoblots for phosphotyrosine residues (Osheroff et al., 1999; Visconti et al., 1995) . This is an excellent laboratory tool, though it is not by nature quantitative, and the technical effort required has precluded this approach from being developed for commercial use. Other assays of capacitation also involve incubating sperm under capacitating conditions, and then treating them with a stimulus to induce acrosome exocytosis. For similar reasons of technical effort, as well as the subjective nature of interpreting the signal in the sperm head (e.g., as when using chlortetracycline as a calcium indicator [Saling & Storey, 1979] ), these assays have also not been used extensively in clinical practice.
Additional data on the inter-and intra-operator reliability of CapScore measurements (Moody et al., 2017) , along with observations on how semen must be handled in order to perform this assay and optimize function (Moody et al., 2017) , support the technical feasibility of this assay and how it might fit into the work flow of a traditional semen analysis. The current demonstration of clinical "fit for purpose" combine with those data to provide a validation of the assay.
Our results strongly suggest that the Cap-Score assay addresses recent calls for the development of practical tests of sperm function to act as a complement to semen analysis (Lamb, 2010; Oehninger et al., 2014; Wang & Swerdloff, 2014) . Clearly, a large percentage of men questioning their fertility and passing World Health Organization semen analysis cut-offs had sperm that were poorly responsive to stimuli for capacitation. The Cap-Score Sperm Function Test should not, however, be the singular test administered and/or considered when evaluating the fertility status of the male partner. This caveat is applicable to all tests of sperm function, as these tests are not meant to detract from or replace, but instead build upon and strengthen, the information provided in the traditional semen analysis (Sakkas, Ramalingam, Garrido, & Barratt, 2015) .
When used in conjunction with traditional, descriptive measures of semen quality, knowledge of the Cap-Score should help clinicians counsel couples to the most appropriate fertility treatment (Palermo, Neri, & Rosenwaks, 2015) . Currently, defects in sperm function go undiagnosed by the traditional semen analysis. This results in half of all cases of male infertility being idiopathic, identified only by repeated failure at natural conception and intrauterine insemination (Aboulghar et al., 2001; Tournaye, 2012) . The current diagnostic algorithm imparts enormous emotional, physical, and financial costs on couples trying to conceive. Integration of the Cap-Score Sperm Function Test into the contemporary diagnostic/treatment algorithm is relatively simple (Figure 9 ), and would allow couples identified with reduced sperm function to be spared cycles of intrauterine insemination that are
Comparison of clinical algorithms between historical reliance on semen analysis versus semen analysis performed in conjunction with Cap-Score. The inclusion of Cap-Score to the clinical algorithm will provide a test of sperm function, offering a valuable complement to the descriptive parameters in the traditional semen analysis. Currently, semen analysis fails to diagnose or identify defects in sperm function. More than 50% of male infertility cases are idiopathic, identified only by repeated failure at natural conception and intrauterine insemination (IUI) (large arrow in flow chart on left). In a new algorithm, inclusive of a traditional semen analysis and the Cap-Score Sperm Function Test, couples with low sperm function would be identified earlier (large arrow near the top of the flow chart on right), and immediately directed to a more appropriate form of assisted reproduction, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Removal of these couples with low sperm function from those pursuing intrauterine insemination would be predicted to result in a higher relative success rate of intrauterine insemination for couples with appropriately high Cap-Scores (large arrow near bottom of flow chart on right) doomed to fail. Instead, these couples could immediately be directed to a more appropriate form of assisted reproductive technology, such as in vitro fertilization or intracytoplasmic sperm injection (Forti & Krausz, 1998) .
Why should an assay of the sperm's ability to capacitate in vitro provide clinically relevant information on sperm function for a large percentage of men? Unlike tests that look for mutations in single genes, a cell-biology approach that evaluates the entire pathway of capacitation enables one to assess the functions of, and relationships among, hundreds or possibly thousands of gene products. Male germ cell development and differentiation in the testis, maturation during epididymal transit, and interaction with seminal plasma and stimuli for capacitation must all be normal for sperm to capacitate and yield a Cap-Score within the reference range.
G M1 localization is highly conserved in the spermatozoa of diverse mammalian species, including mouse, bull, and human . This ganglioside is enriched in the plasma membrane overlying the acrosome, matching the localization of sterols and Caveolin-1, a protein associated with membrane rafts and involved in the regulation of acrosome reaction and capacitation (Selvaraj et al., 2006; Travis et al., 2001 ). G M1 is bound by substances in seminal plasma that help keep the sperm functionally quiescent;
as G M1 -binding proteins such as SVS2 (Seminal vesicle secretory protein 2) are lost from the sperm, these gametes can then capacitate and acquire the ability to fertilize an egg (Kawano & Yoshida, 2007; Kawano, Yoshida, Iwamoto, & Yoshida, 2008) . G M1 acts as an important control point for capacitation because it regulates transient calcium flux required for acrosome exocytosis in response to sterol efflux (Cohen et al., 2014) .
We previously showed that specific patterns of G M1 localization are found in mouse and bull sperm that are responsive to stimuli for capacitation (Selvaraj et al., 2007) . In the cohort of fertile men, our present finding of a mean Cap-Score of 35.3% is roughly consistent with these previous studies in murine and bovine spermatozoa, in which approximately 40% of the spermatozoa showed specific changes in G M1 localization upon exposure to capacitation stimuli (Selvaraj et al., 2007) . These results are also consistent with other studies in which capacitation in murine sperm was measured by protein tyrosine phosphorylation events (Urner, Leppens-Luisier, & Sakkas, 2001 ). Together, these data support the view that in diverse mammalian species, including humans, not all sperm in an ejaculate are functionally equivalent and that G M1 localization is a reasonable readout that is informative of these functional differences.
Of interest, the mean Cap-Score for fertile men in Study 1 (38.4), and the cut-off value that had the most sensitivity (39.5), were both slightly higher than the mean Cap-Score for fertile men in Cohort 1 of and between studies, we could have introduced age-related exclusion criteria; we decided against this because the age range of patients in Study 1 reflected those individuals actually being treated for infertility.
In both Study 1 and Cohort 2 of Study 2, we felt it would be practically important to account for the variation being observed in real life situations.
The An intra-individual variability of 34% in sperm concentration was observed when at least three ejaculates were examined (Carlsen et al., 2004) , while a variance of 54% for concentration and 74% for motility index was also reported (Mallidis et al., 1991) . men with a history of infertility were not considered. We performed a power analysis (Faul, Erdfelder, Lang, & Buchner, 2007) to ensure that our sample size was adequate to establish a normal reference range; this was done using preliminary data from 34 fertile men (mean Cap-Score ± SD; 40 ± 7.1%). An acceptable range about the mean was set at 3%, and a two-tailed t-test at p < 0.01, with a probability of detecting a difference this large of 90%, was applied.
Results showed that a valid standard range could be established with a minimum of 61 individuals, below our cohort of 76 unique individuals. For Cohort 2, semen samples from 122 consenting men, who had been referred to the Urology Group of New Jersey for fertility evaluation, were assessed over a 5-month period. None of the men in this Cohort were excluded because of confounding infertility in their partner, and it is highly likely that a number of these men were actually fertile. In fact, within an unscreened population of couples questioning their fertility, 30-50% of the men would be expected to be fertile since female-factor infertility is expected in 50-70% of infertile couples (Agarwal et al., 2015) . In this Cohort, ages ranged from 22 to 56 years. A single semen sample was obtained from each of the 122 patients. The referring urologist included a semen evaluation with each sample inclusive of morphology, concentration, and total motility. Samples from Cohort 2 were also used to investigate potential relationships between the Cap-Score and traditional semen analysis measures.
| Sample processing
Samples having fewer than 10 million sperm cells were not included in any of the Studies. Samples were liquefied at 37°C for at least 15 min but for no more than 2 h (Moody et al., 2017) . (Osheroff et al., 1999; Parinaud, Vieitez, Vieu, Collet, & Perret, 2000) . Pilot studies showed that this stimulus was as effective in promoting capacitation in human sperm, as measured with the Cap-Score, at 3 h of incubation as albumin was at 6 h . Following incubation, the samples were fixed with paraformaldehyde (Electron Microscopy Services: Hatfield, PA reference 15712) as described (Selvaraj et al., 2006) .
| Sample labeling
Samples were labeled with 2 μg/ml of Cholera Toxin B , conjugated with Alexa Fluor 488 (Thermo Fisher, C34775, USA). After 10 min, 5 μl of the labeled sperm were placed on a microscope slide, overlaid with a cover slip, and moved to an imaging station to be scored. 
| Image acquisition

| Statistical analyses
Analysis of variance, coefficient of variation, Mann-Whitney test,
Lilliefors test, and Chi-square test were performed using XLSTAT (2015) . Linear regression analysis and Student's t-test were carried out using Microsoft Excel (2013). Standard error is reported unless otherwise noted.
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